Skip to nav Skip to content

Antimicrobial Resistance and COVID-19: How Congress Can Address Converging Crises

Facebook Twitter LinkedIn Email

On July 23, IDSA hosted a briefing for congressional staff with BIO, Cystic Fibrosis Foundation, Duke-Margolis Center for Health Policy, Partnership to Fight Infectious Disease and The Pew Charitable Trusts.  The briefing, “Antimicrobial Resistance and COVID-19: How Congress can Address Converging Crises” featured IDSA Treasurer Helen Boucher, MD, FIDSA, a patient, and other experts discussing how AMR and a lack of new antibiotics are complicating care for patients with COVID-19 and other conditions.  The panelists also discussed congressional proposals, including the PASTEUR Act, DISARM Act and increased funding, that could strengthen the antibiotic pipeline and promote antibiotic stewardship.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.